Fingerprint
Dive into the research topics of 'A phase II, multicenter, single-arm study of mipsagargin (G-202) as a second-line therapy following sorafenib for adult patients with progressive advanced hepatocellular carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically